Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Virtual Library Resource
(VLR)
published: 13 Mar 2014
last updated: 12 Oct 2018
Bioscience at a Crossroads (Factsheets): Industrial Biotechnology and the Nagoya Protocol
EN
2013-01
EN
Within this sector, awareness of the Nagoya Protocol and the Convention on Biological Diversity is extremely inconsistent, with some companies and researchers actively involved in signing ABS agreements and attending CBD meetings, and others entirely unaware of the CBD. The timely arrival of the Nagoya Protocol could not only help raise awareness of the CBD and promote the equitable sharing of benefits arising from the use of genetic resources. In conjunction with other policy measures, implementation of the Protocol could also strengthen the potential links between industrial biotechnology, conservation, and the sustainable use of biodiversity.
EN
- Aichi-T16. Nagoya Protocol on ABS
- GBF-T13. Fair and equitable sharing of benefits from genetic resources, digital sequence information and associated traditional knowledge
Migrated information
Format: Text document (e.g. adobe acrobat reader or Word)
EN
Format: Text document (e.g. adobe acrobat reader or Word)
